Management of bacterial prostatitis: what's new?

Area of Science:

• Urology
• Infectious Diseases
• Microbiology

Background:

• Prostatitis is a common condition affecting 10-14% of men.
• Acute bacterial prostatitis involves severe Gram-negative infections requiring broad-spectrum antibiotics.
• Chronic bacterial prostatitis is challenging to diagnose, with only 10% of symptomatic patients having a bacterial infection.

Purpose of the Study:

• To differentiate between chronic bacterial prostatitis and chronic pelvic pain syndrome.
• To review diagnostic methods for bacterial prostatitis.
• To discuss optimal antibiotic therapy for chronic bacterial prostatitis.

Main Methods:

• Review of diagnostic tests including the Meares-Stamey four-glass test and the two-glass test.
• Analysis of common uropathogens implicated in prostatitis.
• Evaluation of antibiotic efficacy and pharmacokinetic properties, focusing on fluoroquinolones.

Main Results:

• The Meares-Stamey or two-glass test is crucial for differentiating chronic bacterial prostatitis from chronic pelvic pain syndrome.
• Common uropathogens are the primary cause of bacterial prostatitis, with ongoing discussion regarding Gram-positive roles.
• Fluoroquinolones, particularly levofloxacin, are effective for chronic bacterial prostatitis, offering superior prostatic penetration and once-daily dosing compared to ciprofloxacin.

Conclusions:

• Accurate diagnosis is essential for effective treatment of prostatitis.
• Levofloxacin represents a preferred therapeutic option for chronic bacterial prostatitis due to its efficacy and pharmacokinetic advantages.
• Further research may clarify the role of specific pathogens in chronic prostatitis.